Literature DB >> 7524186

The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.

P Parham1, K L Arnett, E J Adams, L D Barber, J D Domena, D Stewart, W H Hildebrand, A M Little.   

Abstract

The nucleotide sequence of cDNA encoding the HLA-B73 antigen was determined; it is unusually divergent, differing from other HLA-B alleles by 44-77 nucleotide substitutions. Features that distinguish the B*7301 heavy chain from other HLA-B heavy chains include multiple substitutions in the alpha 3 domain and a duplication-deletion within the transmembrane region that increases the length of B*7301 compared to other HLA-B heavy chains. The duplication-deletion is shared with subsets of B alleles from the homologous gorilla (Gogo-B) and chimpanzee (Patr-B) loci. Other unusual features of B*7301 are individually shared with certain alleles of the HLA-A, HLA-C, HLA-F, Gogo-B and Patr-B loci. The B*7301 molecules has sequence elements in common with members of the B7 crossreacting group in the alpha 1 domain and is shown to possess the ME1 epitope, which is held in common with the B7, B22, B27, B42 and B67 antigens. B*7301 has a unique cysteine at position 270 of the alpha 3 domain which appears accessible but probably does not form disulphide-bonded B*7301 dimers in cell membranes. B*7301 represents a newly discovered but ancient lineage of HLA-B alleles that appears poorly represented in the modern human population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524186     DOI: 10.1111/j.1399-0039.1994.tb02344.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  The shaping of modern human immune systems by multiregional admixture with archaic humans.

Authors:  Laurent Abi-Rached; Matthew J Jobin; Subhash Kulkarni; Alasdair McWhinnie; Klara Dalva; Loren Gragert; Farbod Babrzadeh; Baback Gharizadeh; Ma Luo; Francis A Plummer; Joshua Kimani; Mary Carrington; Derek Middleton; Raja Rajalingam; Meral Beksac; Steven G E Marsh; Martin Maiers; Lisbeth A Guethlein; Sofia Tavoularis; Ann-Margaret Little; Richard E Green; Paul J Norman; Peter Parham
Journal:  Science       Date:  2011-08-25       Impact factor: 47.728

2.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

Review 3.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 4.  B27 polymorphism and peptide repertoire.

Authors:  P Parham
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.

Authors:  Achim K Moesta; Laurent Abi-Rached; Paul J Norman; Peter Parham
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  Gorilla MHC class I gene and sequence variation in a comparative context.

Authors:  Jörg B Hans; Richard A Bergl; Linda Vigilant
Journal:  Immunogenetics       Date:  2017-03-22       Impact factor: 2.846

7.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.